PLYMOUTH MEETING, PA — More than 81% of families with children undergoing treatment for B-cell acute lymphoblastic leukemia experienced employment or marital changes within 26 months of diagnosis, according to research published in October 2026, underscoring the prolonged financial and household pressures associated with childhood cancer care.
The multicenter study, published in JNCCN—Journal of the National Comprehensive Cancer Network, examined family outcomes among 420 children receiving treatment for standard-risk B-cell acute lymphoblastic leukemia, or B-ALL, between September 2010 and April 2013.
Researchers found that household disruptions emerged early in treatment and continued accumulating throughout therapy, which typically lasts approximately two and a half years.
Among randomized participants, 56.2% of families reported at least one household change within approximately two months of diagnosis. That proportion increased to 81.2% by 26 months.
The findings suggest that the consequences of childhood leukemia treatment extend beyond patients’ medical needs, affecting caregivers’ employment, household stability and financial circumstances.
B-ALL is the most common childhood cancer. The research was conducted within a Children’s Oncology Group clinical trial, drawing on a network of more than 200 institutions that collectively treat approximately 80% of newly diagnosed childhood and adolescent cancer cases.
“As providers, we should always be thinking about how to minimize the secondary impacts of cancer therapy,” said lead author Rozalyn L. Rodwin, MD, MHS, of Yale Cancer Center and Smilow Cancer Hospital.
“Families are impacted early and continue to be impacted; therefore, support must be considered as part of cancer care from day one.”
The study also examined whether differences in treatment schedules affected family outcomes.
Researchers compared patients receiving maintenance vincristine and dexamethasone every four weeks with those receiving the medications every 12 weeks.
Families in the 12-week treatment group were less likely to report at least $100 in leukemia-related expenses after randomization.
However, most other family outcomes were similar between the two groups, indicating that less frequent maintenance treatment did not substantially reduce the broader household disruptions measured in the study.
“We had hoped this study would find that reduced treatment intensity led to reduced adverse family outcomes, but for the most part that wasn’t the case,” Rodwin said.
The findings point to a need for financial and family support throughout treatment rather than assistance based primarily on the intensity of a patient’s medical regimen.
Rodwin recommended routine screening of caregivers for financial hardship, unexpected employment changes and other household disruptions, allowing healthcare teams to connect families with appropriate resources.
The research also drew attention to the continuing burden of childhood leukemia treatment despite advances in survival.
Melissa Acquazzino, MD, MS, of the Fred & Pamela Buffett Cancer Center, who was not involved in the study, said the findings demonstrate that treatment-related hardship remains a significant concern for patients and their families.
“Significant financial hardship and family distress can develop early on in treatment and remain throughout, negatively impacting the child’s physical and emotional health,” Acquazzino said.
She called for additional research and investment in multidisciplinary care teams to reduce the burdens associated with treatment.
Acquazzino serves on National Comprehensive Cancer Network guideline panels addressing pediatric aggressive mature B-cell lymphomas and adolescent and young adult oncology.
The study, titled “Adverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children’s Oncology Group AALL0932,” appears in the October 2026 issue of JNCCN.
An accompanying commentary by Acquazzino examines the implications for supportive cancer care.
The findings reinforce the importance of addressing caregiver employment, household finances and family stability as components of pediatric oncology care, with support beginning shortly after diagnosis and continuing through treatment.
The full study and accompanying commentary are available at JNCCN.org.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.